Robinhood, MicroStrategy And Other Big Losers From Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the list of some big stocks recording losses in the previous session.
GoodRx Holdings Q3 EPS $0.07 Beats $0.04 Estimate, Sales $187.32M Beat $185.33M Estimate
GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 percent. This is a 22.22 percent decrease over earnings of $0.09 per share from the
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Where GoodRx Holdings Stands With Analysts
Over the past 3 months, 10 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
10 Analysts Have This to Say About GoodRx Holdings
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings:
JP Morgan Upgrades GoodRx Holdings to Neutral, Lowers Price Target to $8
JP Morgan analyst Doug Anmuth upgrades GoodRx Holdings (NASDAQ:GDRX) from Underweight to Neutral and lowers the price target from $10 to $8.